Fig. 4From: Favourable outcome of multisystem venous thrombosis associated with novel SERPINC1 mutation after treated with dabigatran: a case report with 7-year follow-upThe heterozygous mutation in the SERPINC1 gene (c.233_236dup, p.Val80Alafs*26) was identified in the patient. The red arrow indicates the start of the frameshift duplication in the SERPINC1 gene (A). Sanger sequencing results of the TA cloned products (B). TA cloning and sanger sequencing were performed by Tsingke Biotechnology Co., Ltd. Chromas was used to analyze the sequencing resultsBack to article page